Fred Hutchinson Cancer Research Center

Therapeutic Targeting of Aberrant mRNA Splicing in Myelodysplastic Syndromes
2020

Overview

Fred Hutchinson Cancer Research Center was awarded a $250,000 grant over two years to support early career researcher Dr. Stanley C. Lee.

Details

Dr. Lee will conduct this research with the support of his mentor Dr. Joachim Deeg to identify, validate, and translate novel therapeutic targets with the ultimate goal of expanding treatment options for patients with MDS.

Learn more about Fred Hutchinson Cancer Research Center.